drugset / Trial / NCT02795780

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

NCT02795780

Phase 2 Completed 79 enrolled Avid Radiopharmaceuticals
NaSingle-groupOpen-labelDiagnostic

Summary

This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.

Timeline

Start
2016-08
Primary completion
2017-08-28
Completion
2017-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Flortaucipir Diagnostic / imaging agent 370 mbq Intravenous

Indications